Novel mechanisms could transform standards of care in multiple cancers, MS, and Lupus

Leading science and technology company, Merck KGaA, Darmstadt, Germany have identified five mid- to late-stage assets with first-in-class potential for improving standards of care in several cancers, MS, and Lupus.

read more